MedicaSafe Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 4

MedicaSafe General Information

Description

Developer of drug-device combination products designed to ensure opioid addicts take pills and can only access one at a time. The company's product combines drugs with cloud technologies and provides safe distribution of drugs and medications, enabling physicians to improve clinical insight and patient compliance and manage high-risk medications.

Contact Information

Website
www.medicasafe.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 131 Varick Street
  • Suite 934
  • New York, NY 10013
  • United States
+1 (212)
Primary Industry
Other Devices and Supplies
Other Industries
Other Healthcare Technology Systems
Vertical(s)
HealthTech
Corporate Office
  • 131 Varick Street
  • Suite 934
  • New York, NY 10013
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MedicaSafe Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Later Stage VC 01-Jan-2021 Completed Generating Revenue
10. Later Stage VC (Series B2) 31-Dec-2020 Completed Generating Revenue
9. Debt - PPP 27-Apr-2020 Completed Pre-Clinical Trials
8. Grant 09-Jul-2019 Completed Pre-Clinical Trials
7. Later Stage VC (Series B1) 13-Nov-2018 Completed Pre-Clinical Trials
6. Later Stage VC (Series A2) 01-Mar-2017 Completed Pre-Clinical Trials
5. Grant 01-Jan-2015 Completed Startup
4. Grant 01-Jan-2014 Completed Startup
3. Grant 01-Jan-2012 $1.19M $2M Completed Startup
2. Early Stage VC (Series A) 30-Nov-2010 $2M $2M Completed Startup
To view MedicaSafe’s complete valuation and funding history, request access »

MedicaSafe Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B2
Series B1
Series A2 4,799,992 $0.000100 6% $0.7 $0.7 1x $0.7 12%
Series A 1,327,353 $0.000100 6% $0.45 $0.45 1x $0.45 3.32%
To view MedicaSafe’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

MedicaSafe Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of drug-device combination products designed to ensure opioid addicts take pills and can only access one at a
Other Devices and Supplies
New York, NY
12 As of 2026

North Chesterfield, VA
 

Uppsala, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MedicaSafe Competitors (6)

One of MedicaSafe’s 6 competitors is Indivior, a Corporate Backed or Acquired company based in North Chesterfield, VA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Indivior Corporate Backed or Acquired North Chesterfield, VA
Orexo Formerly VC-backed Uppsala, Sweden
Knoa Pharma Corporate Backed or Acquired Stamford, CT
Otsuka (IT Consulting and Outsourcing) Corporation Tokyo, Japan
Lilly USA Corporation Indianapolis, IN
To view MedicaSafe’s complete competitors history, request access »

MedicaSafe Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 30

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

MedicaSafe Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2019257596-A1 Method, system and apparatus for guiding and tracking medication usage Active 28-Mar-2014
AU-2019257596-B2 Method, system and apparatus for guiding and tracking medication usage Inactive 28-Mar-2014
CA-3137535-A1 Method, system and apparatus for guiding and tracking medication usage Pending 28-Mar-2014
EP-3784198-A1 Method, system and apparatus for guiding and tracking medication usage Active 28-Mar-2014
EP-3784198-A4 Method, system and apparatus for guiding and tracking medication usage Active 28-Mar-2014 G16H20/13
To view MedicaSafe’s complete patent history, request access »

MedicaSafe Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MedicaSafe Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Puget Sound Venture Club Angel Group Minority
Angel (individual) Minority
National Institute on Drug Abuse (NIDA) Government
U.S. Department of Health and Human Services Government
To view MedicaSafe’s complete investors history, request access »

Ready to get started?

Request a free trial

MedicaSafe FAQs

  • When was MedicaSafe founded?

    MedicaSafe was founded in 2007.

  • Where is MedicaSafe headquartered?

    MedicaSafe is headquartered in New York, NY.

  • What is the size of MedicaSafe?

    MedicaSafe has 12 total employees.

  • What industry is MedicaSafe in?

    MedicaSafe’s primary industry is Other Devices and Supplies.

  • Is MedicaSafe a private or public company?

    MedicaSafe is a Private company.

  • What is MedicaSafe’s current revenue?

    The current revenue for MedicaSafe is .

  • How much funding has MedicaSafe raised over time?

    MedicaSafe has raised $11.5M.

  • Who are MedicaSafe’s investors?

    Puget Sound Venture Club, , National Institute on Drug Abuse (NIDA), and U.S. Department of Health and Human Services have invested in MedicaSafe.

  • Who are MedicaSafe’s competitors?

    Indivior, Orexo, Knoa Pharma, Otsuka (IT Consulting and Outsourcing), and Lilly USA are some of the 6 competitors of MedicaSafe.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process